|
Name |
(1R,2R,5S,7R,10R)-5,7-dihydroxy-14-(4-methoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-diene-3,16-dione
|
Molecular Formula | C27H32O7 | |
IUPAC Name* |
(1R,2R,5S,7R,10R)-5,7-dihydroxy-14-(4-methoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-12(17),13-diene-3,16-dione
|
|
SMILES |
C[C@@]12CC[C@@]3([C@@]([C@H]1CC4=C(O2)C=C(OC4=O)C5=CC=C(C=C5)OC)(C(=O)C[C@@H](C3(C)C)O)C)O
|
|
InChI |
InChI=1S/C27H32O7/c1-24(2)21(28)14-22(29)26(4)20-12-17-19(34-25(20,3)10-11-27(24,26)31)13-18(33-23(17)30)15-6-8-16(32-5)9-7-15/h6-9,13,20-21,28,31H,10-12,14H2,1-5H3/t20-,21-,25+,26-,27+/m0/s1
|
|
InChIKey |
OXYZEYLPMGOMEK-UCHDDLIBSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | 102132270 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 468.5 | ALogp: | 2.7 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 102.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 34 | QED Weighted: | 0.679 |
Caco-2 Permeability: | -4.778 | MDCK Permeability: | 0.00002370 |
Pgp-inhibitor: | 0.985 | Pgp-substrate: | 0.816 |
Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.414 |
30% Bioavailability (F30%): | 0.906 |
Blood-Brain-Barrier Penetration (BBB): | 0.841 | Plasma Protein Binding (PPB): | 88.04% |
Volume Distribution (VD): | 0.859 | Fu: | 9.55% |
CYP1A2-inhibitor: | 0.341 | CYP1A2-substrate: | 0.858 |
CYP2C19-inhibitor: | 0.767 | CYP2C19-substrate: | 0.593 |
CYP2C9-inhibitor: | 0.872 | CYP2C9-substrate: | 0.687 |
CYP2D6-inhibitor: | 0.065 | CYP2D6-substrate: | 0.876 |
CYP3A4-inhibitor: | 0.765 | CYP3A4-substrate: | 0.473 |
Clearance (CL): | 7.945 | Half-life (T1/2): | 0.316 |
hERG Blockers: | 0.527 | Human Hepatotoxicity (H-HT): | 0.669 |
Drug-inuced Liver Injury (DILI): | 0.347 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.973 | Maximum Recommended Daily Dose: | 0.936 |
Skin Sensitization: | 0.185 | Carcinogencity: | 0.773 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.963 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002037 | 0.752 | D06XZW | 0.261 | ||||
ENC003232 | 0.725 | D0N0RU | 0.254 | ||||
ENC003130 | 0.685 | D0P1UX | 0.252 | ||||
ENC005020 | 0.445 | D04UTT | 0.248 | ||||
ENC002192 | 0.435 | D09WKB | 0.246 | ||||
ENC000932 | 0.419 | D06HBQ | 0.241 | ||||
ENC002118 | 0.404 | D06GCK | 0.237 | ||||
ENC002044 | 0.400 | D03SKD | 0.234 | ||||
ENC003423 | 0.394 | D0J1ML | 0.234 | ||||
ENC003422 | 0.394 | D02DPU | 0.232 |